Erin Hanlon to Endocannabinoids
This is a "connection" page, showing publications Erin Hanlon has written about Endocannabinoids.
Connection Strength
3.233
-
Beyond the Scale: Exploring the Endocannabinoid System's Impact on Obesity. Curr Diab Rep. 2024 Nov 15; 25(1):6.
Score: 0.931
-
Circadian Misalignment of the 24-hour Profile of Endocannabinoid 2-Arachidonoylglycerol (2-AG) in Obese Adults. J Clin Endocrinol Metab. 2020 03 01; 105(3).
Score: 0.671
-
Impact of circadian rhythmicity and sleep restriction on circulating endocannabinoid (eCB) N-arachidonoylethanolamine (anandamide). Psychoneuroendocrinology. 2020 01; 111:104471.
Score: 0.653
-
Sleep Restriction Enhances the Daily Rhythm of Circulating Levels of Endocannabinoid 2-Arachidonoylglycerol. Sleep. 2016 Mar 01; 39(3):653-64.
Score: 0.509
-
Circadian rhythm of circulating levels of the endocannabinoid 2-arachidonoylglycerol. J Clin Endocrinol Metab. 2015 Jan; 100(1):220-6.
Score: 0.469